Site Home   Gender and Cardiovascular Disease       Introduction to Gender and Health   The Gender Lens Tool

Early use of intravenous beta-blockers in acute MI and beta-blocker therapy initiated before hospital discharge and continued for a minimum of 1 year have shown reduced mortality and re-infarction in patients who have had a myocardial infarction. In fact the success of this therapy is better in women than men[1]. However, beta-blockers are often under prescribed in women post-infarction[2] . The under usage of beta-blockers is associated with advanced age. Whereby, older patients are less likely to be treated with beta-blocker therapy than younger patients.


1. Olsson, G., Wikstrand, J., Warnold, I. Metoprolol induced Reduction in Postinfarction Mortality: Pooled Results from Five Double-blinded Randomized Trials. EurHeart J. 1992;13:28.

2. Nohria, A., Vaccarino, V., and Krumholz, H. Gender Differences in Mortality After Myocardial Infarction: Why Women Fare Worse Than Men. Cardiology Clinics 1998;16(1):45-57.

All references for this section